BPC-157 vs GLP-3 RTA
BPC-157 and GLP-3 RTA come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do BPC-157 and GLP-3 RTA differ?
BPC-157 (Synthetic pentadecapeptide · tissue-repair research) is catalogued under recovery & gut research; GLP-3 RTA (Synthetic triple-agonist peptide) is catalogued under weight & metabolic research. Verve lists 5 reported research applications for BPC-157 and 5 for GLP-3 RTA. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | BPC-157 | GLP-3 RTA |
|---|---|---|
| compound class | Synthetic pentadecapeptide · tissue-repair research | Synthetic triple-agonist peptide |
| research area | recovery & gut | weight & metabolic |
| reported research applications | 5 listed | 5 listed |
| supplied as | single compound | single compound |
| catalog sizes | 10mg · 20mg | 10mg · 20mg · 30mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | not offered | available |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $93.49 | $142.99 |
| availability | in stock | in stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is BPC-157 and what is GLP-3 RTA?
BPC-157 is classified as Synthetic pentadecapeptide · tissue-repair research; GLP-3 RTA as Synthetic triple-agonist peptide. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
BPC-157
Synthetic pentadecapeptide · tissue-repair research
BPC-157 is a synthetic pentadecapeptide, a chain of 15 amino acids, derived from a partial sequence of a protein identified in human gastric juice, sometimes referred to as Body Protection Compound. It is a stable, water-soluble peptide and one of the most frequently cited reference compounds in tissue-repair and cellular research.
full BPC-157 profile →GLP-3 RTA
Synthetic triple-agonist peptide
GLP-3 RTA is a synthetic single-chain peptide engineered to act at three related class B G-protein-coupled receptors at once: the GLP-1 receptor, the GIP receptor, and the glucagon receptor. Its backbone is derived from the incretin peptide family and carries a fatty-acid modification that extends plasma half-life in pre-clinical systems, making it a widely cited reference agonist in incretin-receptor research.
full GLP-3 RTA profile →Which research models is each compound studied in?
BPC-157 sits in recovery & gut research and GLP-3 RTA in weight & metabolic research, so their listed models largely do not intersect. The table lists 5 reported research applications for BPC-157 and 5 for GLP-3 RTA. Rows are per compound, not equivalences.
| BPC-157 — reported research applications | GLP-3 RTA — reported research applications |
|---|---|
| Cell-migration and wound-healing research models | GLP-1, GIP, and glucagon receptor agonism research |
| Angiogenesis and vascular signaling research | cAMP and class B GPCR signaling research models |
| Tendon, ligament, and connective-tissue research models | Comparative single-, dual-, and triple-agonist pharmacology studies |
| Gastrointestinal-tract research | Metabolic-pathway and nutrient-handling research models |
| Nitric-oxide pathway studies | Peptide half-life, lipidation, and stability research |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for BPC-157 and GLP-3 RTA?
BPC-157 is listed from $93.49 and GLP-3 RTA from $142.99. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| BPC-157 | 10mg | $93.49 | in stock |
| BPC-157 | 20mg | $157.49 | in stock |
| GLP-3 RTA | 10mg | $142.99 | in stock |
| GLP-3 RTA | 20mg | $242.99 | in stock |
| GLP-3 RTA | 30mg | $328.99 | in stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about BPC-157 and GLP-3 RTA
What is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide (a pentadecapeptide) based on a sequence found in human gastric juice. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is BPC-157 studied for in research?
In in-vitro and pre-clinical research it is used as a reference compound in models of tissue repair, angiogenesis, cell migration, and extracellular-matrix remodeling. Verve makes no claims about use in humans or animals.
What is GLP-3 RTA?
GLP-3 RTA is a synthetic peptide that acts as an agonist at three receptors — GLP-1, GIP, and glucagon. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is GLP-3 RTA studied for in research?
In in-vitro and pre-clinical models it is used as a reference agonist in incretin-receptor pharmacology, cAMP signaling, and metabolic-pathway research. Verve makes no claims about use in humans or animals.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.